During our Virtual Panel Series discussion on January 13th, Dr. Marjut Salokannel docent joined us to discuss the topic…
Dr. Ana Nordberg, of Lund University, speaks about an EU initiative involving using and sharing genetic databases
During our Virtual Panel Series discussion on January 13th, Dr. Ana Nordberg joined us to discuss the topic…
Dr Mahsa Shabani, of Ghent University, speaks about transparency when using genetic and health data
During our Virtual Panel Series discussion on January 13th, Dr. Mahsa Shabani joined us to discuss…
Prof Kjetil Tasken speaking about the cost of CAR T-cells therapy and inequalities in cancer treatment
Prof Kjetil Tasken speaks about CAR T-cells therapy and inequalities in cancer treatment
Prof. Magnus Essand, of Uppsala University, speaks about oncolytic viruses and their potential as a treatment option
Prof. Magnus Essand, of Uppsala University, joined us for our Virtual Panel Discussion on December 17th.
Prof. Ann Ager, of Cardiff University, speaks about the development of CAR-T Cells
During our Virtual Panel Series discussion on December 17th, our expert panellist’s discussed, Immuno-oncology….
Prof. Rob Jones, of Cancer Research UK Glasgow Clinical Trials Unit, speaks about clinical trials
Prof. Rob Jones, of Cancer Research UK Glasgow Clinical Trials Unit, speaks about the next steps that need to be taken for clinical trials to progress
Dr. Capucine Baldini, speaks about how Gustave Roussy dealt with the first and second waves of the pandemic
Dr. Capucine Baldini, of Gustave Roussy, speaks about how Gustave Roussy dealt with the first and second waves of the pandemic.
Eibhlin Mulroe, of Cancer Trials Ireland, speaks about the re-opening of hospital sites for clinical trials
Eibhlin Mulroe spoke to PMF about the difficulties of performing clinical trials in hospitals during the first and second wave of the pandemic.
PMF Interviews Dr. Capucine Baldini, of Gustave Roussy
Dr Capucine Baldini, Medical Oncologist, Drug Development (DITEP), Institut de Cancérologie Gustave Roussy, will be joining us for our next Virtual Panel Series
PMF Interviews Professor Rob Jones, of Cancer Research UK Glasgow Clinical Trials Unit
Prof. Rob Jones gives us insight into the work being done at Cancer Research UK Glasgow Clinical Trials Unit
Dr. Julien Masliah Planchon speaks about Institut Curie’s use of Molecular Tumour Boards
Dr. Julien Masliah Planchon, of Institut Curie, gave interesting insight into Institut Curie’s use of Molecular Tumour Boards.
Dr. Maud Kamal discusses Advancing Precision Medicine to make better medicine for all patients.
Dr. Maud Kamal, of Institut Curie, joined us for our Virtual Panel Series discussions on November 12, 2020
Prof. Dr. Janne Lehtiö Discusses Data Integrity Issues faced in Healthcare
Our panelist’s delved into the topic of data integrity and how important it is in today’s research and healthcare settings.
Dr. David Tamborero speaks about clinical support software platforms in European Institutions
In this clip from our Virtual Panel Series session on November 12, 2020, Dr. David Tamborero, of Karolinska Institutet, answered an audience question…
There is no better time to make your scientific poster a virtual experience.
Director of Precision Medicine Forum, Steve Coldicott, realised that there was a need for researchers to be able to share their scientific posters online.
Dr. Maurie Markman talks about the role science plays in encouraging patients to return to hospitals
In this clip from our Virtual Panel Series discussion on October 22, 11am EST, Dr. Maurie Markman, talks about the role science plays in encouraging patients to return to hospitals.
Dorothy Erlanger speaks about cancer patient treatment during covid-19
Dorothy Erlanger, Chair of the Patient Advocate Committee at the National Cancer Institute, spoke about the difficulties facing patient treatment during the pandemic.
Dr. Len Lichtenfled discusses Healthcare disparities in the US due to the pandemic
During our Virtual Panel Series discussion on October 22 at 11am EST, we got the perspective of how the pandemic is being dealt with in the US.
Dr. Antonio Calles gives insight into how his hospital are managing cancer patients treatments during the pandemic
For our first Virtual Panel Series session, our expert panellist’s were discussing the impact Covid-19 has had on Cancer treatment and screening.
Professor Justin Stebbing reflects on Healthcare Disparities due to Covid-19
During our first Virtual Panel Series Discussion on October 22, 2020, our expert panellist’s were speaking about the impact Covid-19 has had on cancer treatment and screening.
The University of Oxford Partners with King Abdulaziz University to set up a new Centre for Artificial Intelligence and Precision Medicine
View PostUK Government launches NEW National Genomics Healthcare Strategy
View PostPricey Precision Medicine Often Financially Toxic For Cancer Patients
View PostYOU CAN’T HELP EVERYBODY BUT YOU CAN MAKE SURE YOU HELP THE RIGHT PEOPLE
View PostTO LIVE TOGETHER IS THE ESSENCE OF LIFE
View PostEVERY PATIENT IS UNIQUE
View PostTHERE IS NO PRECISION MEDICINE WITHOUT COLLABORATION
View PostPRECISION MEDICINE SHOULD BECOME NORMAL TO IMPLEMENT IN PRIMARY CARE PRACTICE
View PostWE NEED TO BREAK DOWN THE BARRIERS THAT ARE HOLDING BACK INNOVATION
View PostDATA ANALYSIS, AGGREGATION AND MANAGEMENT HAVE AN ESSENTIAL ROLE TO PLAY IN GAINING INSIGHTS AND WISDOM FROM GENOMIC DATA
View PostTo help patients is the goal of everything
View PostIT’S ALL ABOUT COLLABORATION – ALONE WE CAN’T DO ANYTHING
View PostPrecision medicine and what it means to be human
View PostSweden’s strong tradition in genetic technology
View PostPharmacogenetics the Dutch way
View PostWe need to change our expectations
View PostICON and Genomics England
Published on Apr 25, 2016 The 100,000 Genomes Project is creating the world’s largest genome sequencing project for cancers and rare diseases, and has the potential to transform the diagnosis and treatment of cancers and rare diseases. As Data Management Partner for this transformative project, ICON is using its world-class capabilities to validate and securely manage the large, complex data …
Drawn to Science: T-cell bispecific antibodies
Published on May 31, 2016 At Roche Pharma Research and Early Development, we are working on a novel form of engineered antibodies for cancer immunotherapy that we call T-cell bispecific antibodies. We consider them match-makers between T-Cells and cancer cells. With two handles, they recognize specific markers on the surface of cancer cells. A third handle is designed to hook …
How is Immunotherapy Used to Fight Cancer? | Dana-Farber Cancer Institute | Science Illustrated
Link via Dana-Farber Cancer Institute How does immunotherapy fight cancer? If you take the brakes off the immune system, you can unleash an attack on cancer cells. That’s the theory behind PD-1/PD-L1, a vitally important immunotherapy discovery illustrated in this video.
Chasing Metastatic Cancer Cells
Link via Winship Cancer Institute of Emory University Understanding cancer cell behavior is a fundamental step toward advancing precision medicine. Winship’s Adam Marcus, PhD, shows how his lab is isolating and studying the behavior “leader” cells that may be the key to cancer metastasis.
White House and President Obama Hosts a Precision Medicine Initiative Summit
On the one year anniversary of the launch of the Precision Medicine Initiative, President Obama participates in a panel discussion moderated by Dr. James Hamblin of The Atlantic on the importance of PMI in South Court Auditorium at the White House, February 25, 2016. “Doctors have always recognized that every patient is unique, and doctors have always tried to tailor …
“A family curse” warded off by Canadian genomics research
Watch this Newfoundlanders story about how genomics is offering him protection against a potentially lethal disease.
What is Precision Medicine?
Precision medicine aims to collect, connect, and apply vast amounts of data and information about our health to help guide more precise and predictive medicine worldwide. Learn more at http://precisionmedicine.ucsf.edu/
Right on Target: Precision Medicine to Treat Rare Tumors
Precision medicine is the practice of using a cancer cell’s DNA to guide therapy. Learn how scientists have used precision medicine to treat rare brain tumors. This video was produced in collaboration with Malak Abed and her team in Boston.
Liquid Biopsy Promotes Precision Medicine By Tracking Patient’s Cancer
Published on Nov 4, 2015 In a study published in Nature Communications, Dr. Muhammed Murtaza, who holds a joint appointment at Mayo Clinic and Translational Genomics Research Institute (TGEN), and colleagues, describe an extensive comparison between biopsy results and analysis of ctDNA in a patient with breast cancer. In the following video, Dr. Murtaza describes how circulating tumor DNA in …
CRISPR: A DNA Word Processor for Editing the Genome
Since the discovery of DNA’s fundamental role in building and sustaining life, scientists have dreamed of having the ability to easily edit DNA in very precise ways. This video explores how a group of scientists made a major breakthrough in understanding the bacterial immune response, called the CRISPR/Cas system, and discovered a way to utilize this system to create a …